During his time in industry, Paul led teams at Takeda and Nycomed responsible for developing launch pricing and reimbursement strategies, optimising price of in-market products and providing input into R&D for pipeline products.
Paul is a visiting lecturer at Grenoble Business school and frequently presents on cutting edge pricing and market access topics at major conferences.
Graham’s industry experience includes GSK, start-up biotech and Ferring pharmaceuticals. During his time at Ferring, Graham was Global Head of Market Access and Pricing, taking responsibility for pharmaceutical & diagnostic products and product launches. Graham’s consultancy experience includes both IMS consulting (previously Cambridge Pharma) and Adelphi Values.
As a pricing and market access expert, Graham regularly speaks at conferences and is a guest lecturer at Grenoble Business school.
Our Team Members
Since making the switch to consultancy Hannah has held consultant roles with responsibility for delivering HTA submissions, real-world evidence, value demonstration and health economics projects. Hannah has experience across multiple therapy areas including rare diseases, asthma, diabetes and oncology. She has also carried out projects in biosimilars.
Hannah has a Master of Pharmacy degree from the University of Nottingham and completed her pre-registration training with University Hospitals of Leicester and AstraZeneca.
Prior to joining Remap Consulting, Sarah gained experience at Adelphi Values and AstraZeneca providing support for a variety of projects across various therapy areas.
Fatima gained consultancy experience during her time at Consulting at McCann Health, where she used her analytical skills to produce pricing and reimbursement landscape summaries, strategic recommendation reports and global value dossiers.
During her time at Remap Consulting, Fatima has developed and managed HTA submissions in France, Italy and Sweden and supported client due-diligence processes through commercial assessments of in-licensing opportunities. Fatima is experienced in both secondary and primary research and has conducted key opinion leader and payer insight projects across various EU markets. Fatima has experience supporting clients across a variety of therapeutic areas, including orphan diseases, nephrology and oncology.
Fatima has published a number of research posters on NICE appraisal processes. In 2018, her research poster on NICE appraisals for oncology drugs was selected as a Finalist at ISPOR Barcelona. In 2019, she won a “Best New Investigator Podium Presentation” for her presentation comparing NICE appraisals for oncology and non-oncology drugs at ISPOR Copenhagen.
Fatima has a BSc in Biomedical Sciences from Manchester University.
Prior to joining Remap Consulting, Mike was a Medical Affairs Operations Executive at ViiV Healthcare. He has significant experience in project management, from projects involving clinical data tools to process improvement initiatives, as well as experience in the delivery of training of pricing and reimbursement systems across the world.
Mike has been involved on projects covering a diverse range of healthcare topics, including precision medicine, rare diseases and the treatment of HIV.
Mike has a BSc in Pharmacology from the University of Leeds.
Prior to joining Remap Consulting, Charlotte worked within Astrazeneca in international marketing functions across a range of therapy areas and brand teams.
Powerpoint and Word are Emily’s specialist areas of expertise with an advanced in-depth knowledge of editing, formatting and design. Emily is a proactive & enthusiastic individual with natural creative flair and a ‘can do’ attitude. Prior to joining Remap Consulting, Emily worked at AstraZeneca and Adelphi International Research providing support for a variety of projects across various therapy areas.
Prior to joining Remap Consulting, Edward was an intern consultant at IP Pragmatics, where he gained experience of market research and patent landscape analysis, while assisting in the commercialisation of new technologies within the biosciences. Edward has experience of working within a number of research areas, including genetics, medical devices and plant sciences.
Edward has a BSc in Genetics from the University of Liverpool.
Prior to joining Remap Consulting, Alvaro worked in R&D at the University of California, Berkeley and then at the Manchester Institute of Biotechnology on the production of biopharmaceuticals. In 2019 Alvaro was part of the team that won the ‘Consulting Case Competition’ of the North West Biotech Initiative.
Alvaro holds a Master’s degree in Biotechnology and Enterprise from The University of Manchester.
Andreas is regularly invited as an expert speaker on conferences around Market Access and as a member of advisory board panels to the pharmaceutical industry. He is the founder of the “European Journal of Health Economics”.
Andreas and Remap Consulting have collaborated on a wide range of pricing and market access projects, including payer advisory boards and payer scientific advice meetings.
Ben has worked extensively in Latin America, Asia-Pacific, Middle East & Africa and Eastern European countries, with a particular focus on the BRICMT markets and high-growth developing economies worldwide. He has worked in all major therapy areas, including oncology, diabetes, respiratory medicine and innovative vaccines.
Fluent in Spanish and Portuguese, Ben holds a Master’s degree from Oxford University.